| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | AF123-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | MAB123-SP | |||
| Carrier Free | FAB123V-100UG | |||
| Carrier Free | FAB123U-100UG | |||
| Carrier Free | FAB123T-100UG | |||
| Carrier Free | FAB123S-100UG | |||
| Carrier Free | FAB123R-100UG | |||
| Carrier Free | FAB123N-100UG | |||
| Carrier Free | FAB123G-100UG | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-70701 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | MAB1231-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | MAB6900-SP | |||
| Carrier Free | FAB6900V-100UG | |||
| Carrier Free | FAB6900U-100UG | |||
| Carrier Free | FAB6900S-100UG | |||
| Carrier Free | FAB6900R-100UG | |||
| Carrier Free | FAB6900N-100UG | |||
| Carrier Free | FAB6900G-100UG | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35242-1mg | |||
| Carrier-Free | NBP2-35242-100ug | |||
| Carrier-Free | NBP2-35242-500ug | |||
![Immunohistochemistry-Paraffin: CD23/Fc epsilon RII Antibody (EBVCS2) [NBP1-43433] - Human colon tissue stained with . IHC-P image submitted by a verified customer review.](http://images.novusbio.com/fullsize/CD23-Fc-epsilon-RII-Antibody-EBVCS2-Immunohistochemistry-Paraffin-NBP1-43433-img0007.jpg "Immunohistochemistry-Paraffin: CD23/Fc epsilon RII Antibody (EBVCS2) [NBP1-43433] - Human colon tissue stained with . IHC-P image submitted by a verified customer review.")
![Flow Cytometry: CD23/Fc epsilon RII Antibody (EBVCS2) [NBP1-43433] - Analysis using the PerCP/Cy5.5 conjugate of NBP1-43433. Staining of normal human peripheral blood cells with Anti-Human CD19 FITC and Anti-Human CD23 PerCP-Cy5.5. Cells in the lymphocyte gate were used for analysis.](http://images.novusbio.com/fullsize/CD23-Fc-epsilon-RII-Antibody-EBVCS2-Flow-Cytometry-NBP1-43433-img0005.jpg)
![Flow Cytometry: CD23/Fc epsilon RII Antibody (EBVCS2) [NBP1-43433] - Staining of normal human peripheral blood cells with 0.5 ug of Mouse IgG1 kappa Isotype Control Purified (open histogram) or 0.25 ug of Anti-Human CD23 Purified (filled histogram) followed by Anti-Mouse IgG FITC. Cells in the lymphocyte gate were used for analysis.](http://images.novusbio.com/fullsize/CD23-Fc-epsilon-RII-Antibody-EBVCS2-Flow-Cytometry-NBP1-43433-img0001.jpg)
![Flow Cytometry: CD23/Fc epsilon RII Antibody (EBVCS2) [NBP1-43433] - Analysis using the PE conjugate of NBP1-43433. Analysis of human peripheral blood leukocytes using CD23 PE conjugate. This can be used at less than or equal to 0.5 ug per test. Cell number should be determined empirically but can range from 10^5 to 10^8 cells/test.](http://images.novusbio.com/fullsize/CD23-Fc-epsilon-RII-Antibody-EBVCS2-Flow-Cytometry-NBP1-43433-img0004.jpg)
![Immunohistochemistry-Paraffin: CD23/Fc epsilon RII Antibody [NBP1-85776] - Staining in human lymph node and liver tissues using anti-FCER2 antibody. Corresponding FCER2 RNA-seq data are presented for the same tissues.](http://images.novusbio.com/fullsize/CD23-Fc-epsilon-RII-Antibody-Immunohistochemistry-Paraffin-NBP1-85776-img0007.jpg "<b>Orthogonal Strategies Validation. </b>Immunohistochemistry-Paraffin: CD23/Fc epsilon RII Antibody [NBP1-85776] - Staining in human lymph node and liver tissues using anti-FCER2 antibody. Corresponding FCER2 RNA-seq data are presented for the same tissues.")
![<b>Orthogonal Strategies Validation. </b>Western Blot: CD23/Fc epsilon RII Antibody [NBP1-85776] - Analysis in control (vector only transfected HEK293T lysate) and FCER2 over-expression lysate (Co-expressed with a C-terminal myc-DDK tag (3.1 kDa) in mammalian HEK293T cells).](http://images.novusbio.com/fullsize/CD23-Fc-epsilon-RII-Antibody-Western-Blot-NBP1-85776-img0008.jpg)
![Immunohistochemistry-Paraffin: CD23/Fc epsilon RII Antibody [NBP1-85776] - Staining of human liver shows low expression as expected.](http://images.novusbio.com/fullsize/CD23-Fc-epsilon-RII-Antibody-Immunohistochemistry-Paraffin-NBP1-85776-img0005.jpg)
![Immunohistochemistry-Paraffin: CD23/Fc epsilon RII Antibody [NBP1-85776] - Staining of human lymph node shows high expression.](http://images.novusbio.com/fullsize/CD23-Fc-epsilon-RII-Antibody-Immunohistochemistry-Paraffin-NBP1-85776-img0006.jpg)
![Immunohistochemistry-Paraffin: CD23/Fc epsilon RII Antibody [NBP1-85776] - Staining of human skin shows no positivity in squamous epithelial cells as expected.](http://images.novusbio.com/fullsize/antibody/nbp1-85776_rabbit-polyclonal-cd23-fc-epsilon-rii-antibody-immunohistochemistry-paraffin-2712025115829..png)
![Immunohistochemistry-Paraffin: CD23/Fc epsilon RII Antibody [NBP1-85776] - Staining of human kidney shows no positivity in cells in tubules as expected.](http://images.novusbio.com/fullsize/antibody/nbp1-85776_rabbit-polyclonal-cd23-fc-epsilon-rii-antibody-immunohistochemistry-paraffin-2712025115935..png)
![Western Blot: CD23/Fc epsilon RII Antibody (OTI2B6) [NBP2-45624] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY CD23.](http://images.novusbio.com/fullsize/CD23-Fc-epsilon-RII-Antibody-OTI2B6-Western-Blot-NBP2-45624-img0003.jpg "Western Blot: CD23/Fc epsilon RII Antibody (OTI2B6) [NBP2-45624] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY CD23.")
![Immunohistochemistry: CD23/Fc epsilon RII Antibody (OTI2B6) [NBP2-45624] - Analysis of Carcinoma of Human bladder tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/CD23-Fc-epsilon-RII-Antibody-OTI2B6-Immunohistochemistry-NBP2-45624-img0002.jpg)
![Flow Cytometry: CD23/Fc epsilon RII Antibody (OTI2B6) [NBP2-45624] - analysis of living 293T cells transfected with FCER2 overexpression plasmid .](http://images.novusbio.com/fullsize/CD23-Fc-epsilon-RII-Antibody-OTI2B6-Flow-Cytometry-NBP2-45624-img0004.jpg)
![Immunohistochemistry: CD23/Fc epsilon RII Antibody (OTI2B6) [NBP2-45624] - Analysis of Human lymphoma tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/CD23-Fc-epsilon-RII-Antibody-OTI2B6-Immunohistochemistry-NBP2-45624-img0001.jpg)
![Flow Cytometry: CD23/Fc epsilon RII Antibody (OTI2B6) [NBP2-45624] - analysis of living RPMI-8226 cells, using anti-FCER2 antibody , compared to an isotype control (green), and a PBS control (blue) (1:100).](http://images.novusbio.com/fullsize/CD23-Fc-epsilon-RII-Antibody-OTI2B6-Flow-Cytometry-NBP2-45624-img0005.jpg)
![Western Blot: CD23/Fc epsilon RII Antibody (OTI2B6) - Azide and BSA Free [NBP2-70701] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY CD23.](http://images.novusbio.com/fullsize/CD23-Fc-epsilon-RII-Antibody-OTI2B6-Azide-and-BSA-Free-Western-Blot-NBP2-70701-img0001.jpg "Western Blot: CD23/Fc epsilon RII Antibody (OTI2B6) - Azide and BSA Free [NBP2-70701] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY CD23.")
![Immunohistochemistry: CD23/Fc epsilon RII Antibody (OTI2B6) - Azide and BSA Free [NBP2-70701] - Analysis of Carcinoma of Human bladder tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/CD23-Fc-epsilon-RII-Antibody-OTI2B6-Azide-and-BSA-Free-Immunohistochemistry-NBP2-70701-img0004.jpg)
![Flow Cytometry: CD23/Fc epsilon RII Antibody (OTI2B6) - Azide and BSA Free [NBP2-70701] - Analysis of living 293T cells transfected with FCER2 overexpression plasmid .](http://images.novusbio.com/fullsize/CD23-Fc-epsilon-RII-Antibody-OTI2B6-Azide-and-BSA-Free-Flow-Cytometry-NBP2-70701-img0003.jpg)
![Immunohistochemistry: CD23/Fc epsilon RII Antibody (OTI2B6) - Azide and BSA Free [NBP2-70701] - Analysis of Human lymphoma tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/CD23-Fc-epsilon-RII-Antibody-OTI2B6-Azide-and-BSA-Free-Immunohistochemistry-NBP2-70701-img0005.jpg)
![Flow Cytometry: CD23/Fc epsilon RII Antibody (OTI2B6) - Azide and BSA Free [NBP2-70701] - Analysis of living RPMI-8226 cells, using anti-FCER2 antibody , compared to an isotype control (green), and a PBS control (blue) (1:100).](http://images.novusbio.com/fullsize/CD23-Fc-epsilon-RII-Antibody-OTI2B6-Azide-and-BSA-Free-Flow-Cytometry-NBP2-70701-img0002.jpg)
![N/A CD23/Fc epsilon RII [HRP]](http://images.novusbio.com/fullsize2/DATA_CD23_DCD230_ELISA_619.jpg "N/A CD23/Fc epsilon RII [HRP]")
![N/A CD23/Fc epsilon RII [HRP]](http://images.novusbio.com/fullsize2/CD23_DCD230_ELISA_57.jpg)
![N/A CD23/Fc epsilon RII [Biotin]](http://images.novusbio.com/fullsize2/DATA_CD23_DY6900_ELISA_2182.jpg "N/A CD23/Fc epsilon RII [Biotin]")
![SDS-Page: Recombinant Human CD23/Fc epsilon RII Protein [NBP2-35242]](http://images.novusbio.com/fullsize/nbp2-35242_recombinant-human-cd23-fc-epsilon-rii-protein-512024857292.png "SDS-Page: Recombinant Human CD23/Fc epsilon RII Protein [NBP2-35242]")